Zemplar Drug Interactions
Currently displaying 123 drugs known to have a moderate interaction with Zemplar (paricalcitol).
- 12 major drug interactions
- 123 moderate drug interactions
Moderate interactions with Zemplar (paricalcitol)
Note: Showing generic names only.
A
B
C
- calcipotriene topical
- calcitriol topical
- carbamazepine
- ceritinib
- chlorothiazide
- chlorthalidone
- cholestyramine
- clarithromycin
- cobicistat
- colesevelam
- colestipol
D
E
F
H
I
K
L
M
- magnesium amino acids chelate
- magnesium aspartate
- magnesium carbonate
- magnesium chloride
- magnesium citrate
- magnesium gluconate
- magnesium glycinate
- magnesium hydroxide
- magnesium lactate
- magnesium malate
- magnesium oxide
- magnesium salicylate
- magnesium sulfate
- magnesium taurate
- magnesium threonate
- maralixibat
- mavacamten
- mephobarbital
- methyclothiazide
- metolazone
- mibefradil
- miconazole
- mitotane
N
O
P
- pacritinib
- pemigatinib
- pentobarbital
- pexidartinib
- phenobarbital
- phenytoin
- pirtobrutinib
- polythiazide
- posaconazole
- pralsetinib
- primidone
R
S
- secobarbital
- sevelamer
- sodium iodide i-123
- sodium iodide-i-131
- somapacitan-beco
- somatrem
- somatrogon
- somatropin
- sotorasib
- st. john's wort
- stiripentol
- sucroferric oxyhydroxide
T
V
Zemplar disease interactions
There are 4 disease interactions with Zemplar (paricalcitol) which include:
More about Zemplar (paricalcitol)
- Zemplar consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: vitamins
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.